Last reviewed · How we verify
NCT05983055
Steroid Injection for Sickle Cell Arthropathy Pain Therapy
trial testing Dexamethasone 20mg in Sickle Cell Disease in 50 participants. Completed in 31 March 2024.
31 March 2024
Quick facts
| Lead sponsor | Salem Anaesthesia Pain Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 30 January 2018 |
| Primary completion | 31 March 2024 |
| Estimated completion | 31 March 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Dexamethasone 20mg — full drug profile →
Conditions studied
- Sickle Cell Disease — all drugs for Sickle Cell Disease →
- Sickle Cell Abnormality — all drugs for Sickle Cell Abnormality →
Sponsor
Salem Anaesthesia Pain Clinic
Who can join
Adults 20 to 99, any sex, with Sickle Cell Disease or Sickle Cell Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sickle cell disease (SCD) is associated with arthropathy. Arthropathy may require periarticular corticosteroid injection therapy. This observational study examines efficacy, and safety of steroid injections in SCD patients. Data collection includes patient's gender, age, race, smoking history, alcohol intake, analgesic use, pain score, sleep quality, limb joint injections, post-injection analgesia, and post-injection complication. Pain is measured using numeric pain scale. Sleep quality is measured using Likert scale.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05983055
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexamethasone 20mg
Trials testing the same drug.
- NCT05205252 — A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. · Phase 1, PHASE2 · withdrawn
- NCT03242460 — The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-i · Phase 2 · completed
Other recruiting trials for Sickle Cell Disease
Currently open trials in the same condition.
- NCT07369024 — Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults · Phase 2 · recruiting
- NCT06016634 — Alendronate for Osteonecrosis in Adults With Sickle Cell Disease · Phase 2 · recruiting
- NCT06260891 — Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial · Phase 2 · recruiting
- NCT07222475 — Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease · NA · recruiting
- NCT07224360 — Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) · Phase 2 · recruiting
Other Salem Anaesthesia Pain Clinic trials
Trials by the same sponsor.
- NCT05898529 — COVID Infection in Pediatric Surgical Patient · recruiting
- NCT05618002 — Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients · recruiting
- NCT05277038 — Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients · completed
- NCT06802562 — Medical Assistance in Dying Requests in Pain Clinic · completed
- NCT05950243 — COVID-19 Disease & Vaccine Survey in Africa · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05983055 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salem Anaesthesia Pain Clinic
- Last refreshed: 27 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05983055.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing